News Releases Year: All News201920182017201620152014201320122011 Items per page All News2550 September 7, 2016 Summary ToggleAllena Pharmaceuticals Strengthens Leadership Team, Names Edward Wholihan as Chief Financial Officer and Robert Alexander, PhD, to Board of Directors Read more June 2, 2016 Summary ToggleAllena Pharmaceuticals to Present at the 2016 Jefferies Healthcare Conference Read more May 5, 2016 Summary ToggleFDA Grants Orphan Drug Designation to Allena’s Investigational Therapy for the Treatment of Pediatric Hyperoxaluria Read more March 1, 2016 Summary ToggleAllena Pharmaceuticals to Present at the 36th Annual Cowen and Company Health Care Conference Read more February 10, 2016 Summary ToggleAllena Pharmaceuticals Initiates Patient Treatment in Third Phase 2 Trial of ALLN-177 for Secondary Hyperoxaluria Read more January 8, 2016 Summary ToggleAllena Pharmaceuticals to Present at the 34th Annual J.P. Morgan Healthcare Conference Read more December 5, 2015 Summary ToggleAllena Pharmaceuticals Raises $53 Million in Series C Financing Read more November 12, 2015 Summary ToggleAllena Pharmaceuticals Announces Presentation of Successful Phase 2 Data from ALLN-177 Program at American Society of Nephrology Kidney Week Read more November 4, 2015 Summary ToggleAllena Pharmaceuticals To Present Phase 2 Data on ALLN-177 Program at ASN Kidney Week 2015 Read more August 4, 2015 Summary ToggleAllena Pharmaceuticals Initiates Phase 2b Trial of ALLN-177 for Secondary Hyperoxaluria Read more Pagination First page First Previous page Previous … Page 3 Current page 4 Page 5 Page 6 Next page Next Last page Last
